Glucagon-like peptide-1 receptor agonists in schizophrenia spectrum disorders: A systematic review and meta-analysis of efficacy, safety and mental health outcomes.
- DOI
- 10.1002/bcp.70892
- Published
- 2026 Nov 9
- Container
- British journal of clinical pharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/bcp.70892,
title = {Glucagon-like peptide-1 receptor agonists in schizophrenia spectrum disorders: A systematic review and meta-analysis of efficacy, safety and mental health outcomes.},
author = {de Aguiar DR and Pereira SIDS and Castro PB and Carneiro CRO and de Araujo JC and de Souza RF and da Silva OAFS and Ferreira MHL and Bolsoni BLF and Carvas Junior N and Louzã MR},
year = {2026},
journal = {British journal of clinical pharmacology},
doi = {10.1002/bcp.70892},
url = {https://doi.org/10.1002/bcp.70892}
}RIS
TY - JOUR TI - Glucagon-like peptide-1 receptor agonists in schizophrenia spectrum disorders: A systematic review and meta-analysis of efficacy, safety and mental health outcomes. AU - de Aguiar DR AU - Pereira SIDS AU - Castro PB AU - Carneiro CRO AU - de Araujo JC AU - de Souza RF AU - da Silva OAFS AU - Ferreira MHL AU - Bolsoni BLF AU - Carvas Junior N AU - Louzã MR PY - 2026 JO - British journal of clinical pharmacology DO - 10.1002/bcp.70892 UR - https://doi.org/10.1002/bcp.70892 ER -
APA
DR, D. A., SIDS, P., PB, C., CRO, C., JC, D. A., RF, D. S., OAFS, D. S., MHL, F., BLF, B., N, C. J., & MR, L. (2026). Glucagon-like peptide-1 receptor agonists in schizophrenia spectrum disorders: A systematic review and meta-analysis of efficacy, safety and mental health outcomes.. British journal of clinical pharmacology. https://doi.org/10.1002/bcp.70892
Source records
- pubmed · retrieved 2026-11-10T05:11:10.602Z